Lv21
180 积分 2021-10-20 加入
Parts and ICRAFTs: Finding new immunotherapy targets
11天前
已完结
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
9个月前
已完结
Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
9个月前
已完结
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
9个月前
已完结
Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer
9个月前
已完结
EGFR signaling pathway as therapeutic target in human cancers
9个月前
已完结
Ponatinib‐review of historical development, current status, and future research
9个月前
已完结
Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer
9个月前
已完结
Ponatinib: An update on its drug targets, therapeutic potential and safety
9个月前
已完结
Acquired resistance mechanisms to osimertinib: The constant battle
9个月前
已完结
皖公网安备34019202002308
